Loading...
Redefining overweight and obesity in rheumatoid arthritis patients
Stavropoulos-Kalinoglou, Antonios Metsios, Giorgos S. Koutedakis, Yiannis Nevill, Alan M. Douglas, Karen M. J. Jamurtas, Athanasios Z. van Zanten, J. Labib, M. Kitas, George D.
Stavropoulos-Kalinoglou, Antonios
Metsios, Giorgos S.
Koutedakis, Yiannis
Nevill, Alan M.
Douglas, Karen M. J.
Jamurtas, Athanasios Z.
van Zanten, J.
Labib, M.
Kitas, George D.
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2007
Submitted date
Subjects
Alternative
Abstract
OBJECTIVES: To assess whether body mass index (BMI) and body fat (BF) differ between rheumatoid arthritis (RA) patients, patients with non-inflammatory arthritis (osteoarthritis, OA) and healthy individuals, and whether disease specific measures of adiposity are required to accurately reflect BF in these groups. METHODS: 641 individuals were assessed for BMI (kg/m(2)) and BF (bioelectrical impedance). Of them, 299 (174 RA, 43 OA and 82 healthy controls (HC)) formed the observation group and 342 (all RA) the validation group. RA disease characteristics were collected. RESULTS: ANOVA revealed significant differences between disease groups for BMI (p<0.05) and BF (p<0.001). ANCOVA showed that age accounted for the differences in BMI (F(1,294) = 5.10, p<0.05); age (F(1,293) = 22.43, p<0.001), sex (F(1,293) = 380.90, p<0.001) and disease (F(2, 293) = 18.7, p<0.001) accounted for the differences in BF. For a given BF, patients with RA exhibited BMI levels reduced by 1.83 kg/m(2) (p<0.001) compared to HC; there were no significant differences between OA and HC. A predictive model for BF was developed (R(2) = 0.769, p<0.001) and validated using limits of agreement Analysis against measured BF in the validation group (95%LIM(AG) = 6.17; CV = 8.94). CONCLUSIONS: In individuals with RA, BMI cut-off points should be reduced by 2 kg/m(2) (that is, to 23 kg/m(2) for overweight and 28 kg/m(2) for obesity). The equation developed can be used to accurately predict BF from BMI in RA patients. These findings may be important in the context of the cardiovascular comorbidity of RA.
Citation
Annals of the Rheumatic Diseases, 66 (10): 1316-21
Publisher
Journal
Research Unit
PubMed ID
17289757
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
Series/Report no.
ISSN
0003-4967